|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hutchinson DJ and Klein KC: Human
papillomavirus disease and vaccines. Am J Health Syst Pharm.
65:2105–2112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Markowitz LE, Dunne EF, Saraiya M, Lawson
HW, Chesson H and Unger ER: Centers for Disease Control and
Prevention (CDC); Advisory Committee on Immunization Practices
(ACIP): Quadrivalent human papillomavirus vaccine: Recommendations
of the advisory committee on immunization practices (ACIP). MMWR
Recomm Rep. 56:1–24. 2007.PubMed/NCBI
|
|
5
|
Xu J, Liu H, Yang Y, Wang X, Liu P, Li Y,
Meyers C, Banerjee NS, Wang HK, Cam M, et al: Genome-wide profiling
of cervical RNA-binding proteins identifies human papillomavirus
regulation of RNASEH2A expression by viral E7 and E2F1. MBio.
10:2019. View Article : Google Scholar
|
|
6
|
Lee SY, Meier R, Furuta S, Lenburg ME,
Kenny PA, Xu R and Bissell MJ: FAM83A confers EGFR-TKI resistance
in breast cancer cells and in mice. J Clin Invest. 122:3211–3220.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fulcher LJ, Bozatzi P, Tachie-Menson T, Wu
KZL, Cummins TD, Bufton JC, Pinkas DM, Dunbar K, Shrestha S, Wood
NT, et al: The DUF1669 domain of FAM83 family proteins anchor
casein kinase 1 isoforms. Sci Signal. 11:eaao23412018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Dong X, Yin Y, Su Y, Xu Q, Zhang Y,
Pang X, Zhang Y and Chen W: BJ-TSA-9, a novel human tumor-specific
gene, has potential as a biomarker of lung cancer. Neoplasia.
7:1073–1080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel CA and Jackson MW: HER2-positive
breast cancer cells expressing elevated FAM83A are sensitive to
FAM83A loss. PLoS One. 12:pp. e01767782017, View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grant S: FAM83A and FAM83B: Candidate
oncogenes and TKI resistance mediators. J Clin Invest.
122:3048–3051. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Huang J, Liu Z, Liang Q, Zhang N
and Jin Y: FAM83A is amplified and promotes cancer stem cell-like
traits and chemore-sistance in pancreatic cancer. Oncogenesis.
6:pp. e3002017, View Article : Google Scholar
|
|
12
|
Snijders AM, Lee SY, Hang B, Hao W,
Bissell MJ and Mao JH: FAM83 family oncogenes are broadly involved
in human cancers: An integrative multi-omics approach. Mol Oncol.
11:167–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Xiao X, Ji X, Liu B and Amos CI:
RNA-seq analysis of lung adenocarcinomas reveals different gene
expression profiles between smoking and nonsmoking patients. Tumour
Biol. 36:8993–9003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cipriano R, Miskimen KL, Bryson BL, Foy
CR, Bartel CA and Jackson MW: Conserved oncogenic behavior of the
FAM83 family regulates MAPK signaling in human cancer. Mol Cancer
Res. 12:1156–1165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pawitan Y, Bjöhle J, Amler L, Borg AL,
Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al: Gene
expression profiling spares early breast cancer patients from
adjuvant therapy: Derived and validated in two population-based
cohorts. Breast Cancer Res. 7:R953–R964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Zhou Q, Wang X, Yu Z, Wu X, Chen X, Li J,
Zhu Z, Liu B and Su L: Transducin (β)-like 1 X-linked receptor 1
promotes gastric cancer progression via the ERK1/2 pathway.
Oncogene. 36:1873–1886. 2017. View Article : Google Scholar
|
|
18
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: Accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Robinson JT, Thorvaldsdóttir H, Winckler
W, Guttman M, Lander ES, Getz G and Mesirov JP: Integrative
genomics viewer. Nat Biotechnol. 29:24–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Y, Yu H, Liang X, Xu J and Cai X:
Chk1-induced CCNB1 overexpression promotes cell proliferation and
tumor growth in human colorectal cancer. Cancer Biol Ther.
15:1268–1279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Winograd-Katz SE, Fässler R, Geiger B and
Legate KR: The integrin adhesome: From genes and proteins to human
disease. Nat Rev Mol Cell Biol. 15:273–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamidi H and Ivaska J: Every step of the
way: Integrins in cancer progression and metastasis. Nat Rev
Cancer. 18:533–548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seguin L, Desgrosellier JS, Weis SM and
Cheresh DA: Integrins and cancer: Regulators of cancer stemness,
metastasis, and drug resistance. Trends Cell Biol. 25:234–240.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raab-Westphal S, Marshall JF and Goodman
SL: Integrins as therapeutic targets: Successes and cancers.
Cancers (Basel). 9. pp. 1102017, View Article : Google Scholar
|
|
26
|
Hamidi H, Pietilä M and Ivaska J: The
complexity of integrins in cancer and new scopes for therapeutic
targeting. Br J Cancer. 115:1017–1023. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cipriano R, Graham J, Miskimen KL, Bryson
BL, Bruntz RC, Scott SA, Brown HA, Stark GR and Jackson MW: FAM83B
mediates EGFR- and RAS-driven oncogenic transformation. J Clin
Invest. 122:3197–3210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bartel CA, Parameswaran N, Cipriano R and
Jackson MW: FAM83 proteins: Fostering new interactions to drive
oncogenic signaling and therapeutic resistance. Oncotarget.
7:52597–52612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ojesina AI, Lichtenstein L, Freeman SS,
Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio
L, Cibulskis K, Bertelsen B, et al: Landscape of genomic
alterations in cervical carcinomas. Nature. 506:371–375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X,
Ding W, Yu L, Wang X, Wang L, et al: Genome-wide profiling of HPV
integration in cervical cancer identifies clustered genomic hot
spots and a potential microhomology-mediated integration mechanism.
Nat Genet. 47:158–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ito Y, Miyoshi E, Sasaki N, Kakudo K,
Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et
al: Polo-like kinase 1 overexpression is an early event in the
progression of papillary carcinoma. Br J Cancer. 90:414–418. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Cárcer G, Venkateswaran SV, Salgueiro
L, El Bakkali A, Somogyi K, Rowald K, Montañés P, Sanclemente M,
Escobar B, de Martino A, et al: Plk1 overexpression induces
chromosomal instability and suppresses tumor development. Nat
Commun. 9:30122018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Munger K, Gwin TK and McLaughlin-Drubin
ME: p16 in HPV-associated cancers. Oncotarget. 4:1864–1865. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malhone C and Longatto-Filho A: Cervical,
ovarian and endometrial tumor markers: Potential clinical value.
Semin Ultrasound CT MR. 40:350–357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van der Flier A and Sonnenberg A: Function
and interactions of integrins. Cell Tissue Res. 305:285–298. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hood JD and Cheresh DA: Role of integrins
in cell invasion and migration. Nat Rev Cancer. 2:91–100. 2002.
View Article : Google Scholar
|
|
38
|
Cagnet S, Faraldo MM, Kreft M, Sonnenberg
A, Raymond K and Glukhova MA: Signaling events mediated by α3β1
integrin are essential for mammary tumorigenesis. Oncogene.
33:4286–4295. 2014. View Article : Google Scholar
|
|
39
|
White DE, Kurpios NA, Zuo D, Hassell JA,
Blaess S, Mueller U and Muller WJ: Targeted disruption of
beta1-integrin in a transgenic mouse model of human breast cancer
reveals an essential role in mammary tumor induction. Cancer Cell.
6:159–170. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roman J, Ritzenthaler JD, Roser-Page S,
Sun X and Han S: alpha5beta1-integrin expression is essential for
tumor progression in experimental lung cancer. Am J Respir Cell Mol
Biol. 43:684–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brooks PC, Clark RA and Cheresh DA:
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
Science. 264:569–571. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trusolino L, Bertotti A and Comoglio PM: A
signaling adapter function for alpha6beta4 integrin in the control
of HGF-dependent invasive growth. Cell. 107:643–654. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Serini G, Trusolino L, Saggiorato E,
Cremona O, De Rossi M, Angeli A, Orlandi F and Marchisio PC:
Changes in integrin and E-cadherin expression in neoplastic versus
normal thyroid tissue. J Natl Cancer Inst. 88:442–449. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Khwaja A, Rodriguez-Viciana P, Wennström
S, Warne PH and Downward J: Matrix adhesion and Ras transformation
both activate a phosphoinositide 3-OH kinase and protein kinase
B/Akt cellular survival pathway. EMBO J. 16:2783–2793. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shaw LM, Rabinovitz I, Wang HH, Toker A
and Mercurio AM: Activation of phosphoinositide 3-OH kinase by the
alpha6beta4 integrin promotes carcinoma invasion. Cell. 91:949–960.
1997. View Article : Google Scholar
|
|
46
|
Rathinam R and Alahari SK: Important role
of integrins in the cancer biology. Cancer Metastasis Rev.
29:223–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
FIGO Committee on Gynecologic Oncology:
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynaecol Obstet. 125:97–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
